|
| Study | Patient age | Etiology of coronary obstruction | Location of coronary obstruction | Catheter used | Wire used | Balloon used | Stent used | Antiplatelet therapy | Follow-up interval and modality |
|
| Chrysant 2005 | 3 months | Tissue flap from surgical anastomotic site | 70% mid LMCA | — | — | 3.0 × 10 mm Maverick | 2.25 × 8 mm Sonic Hepacoat | Aspirin (1/4 tablet) | Echo at 2 and 6 months, CTA at 6 months |
| Hallbergson 2015 | 5 weeks | Stenosis one month postoperatively | Near-total occlusion of LMCA | 4 Fr Judkins right coronary | 0.014 intermediate support | — | 2.5 × 8 mm MiniVision | Aspirin 2-4 mg/kg/day and clopidogrel 0.2-0.4 mg/kg/day | Angiography at 3 months |
| Kaichi 2011 | 9 months | Stenosis one month postoperatively | Severe stenosis of LMCA | 4.2 Fr Judkins left, 15 mm | 6 Fr internal mammary artery guiding, 0.014 ACS Hi-Torque balance middle weight | 2.5-20 mm over the wire Maverick PTCA for predilation, 3.5–12 mm monorail system Quantum Maverick PTCA for postdilation | Sirolimus-eluting Cypher | Aspirin 2 mg/kg/day for life, ticlopidine 4-5 mg/kg/day × 6 months | Angiography at 4, 12, and 67 months |
| Paech 2015 | 6 months | Stenosis 29 days postoperatively | 90% LMCA | 4 Fr left coronary, 1.5 modified supertorque | 0.014 coronary guide | Maverick Bloomington × 12 mm | Prometheus AL 3.0 × 8 mm | Acetylsalicylic acid and clopidogrel followed by acetylsalicylic acid only after platelet function testing | Angiography at 10 days and 3 and 8 months |
|
